technetium tc 99m pentetate has been researched along with Hyperkyphosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blackshaw, PE; Dansereau, RJ; Fairbairn, KJ; Frier, M; Hosking, D; Kinghorn, T; Perkins, AC; San, P; Spiller, RC | 1 |
1 trial(s) available for technetium tc 99m pentetate and Hyperkyphosis
Article | Year |
---|---|
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density Conservation Agents; Esophagus; Etidronic Acid; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Kyphosis; Male; Middle Aged; Radionuclide Imaging; Risedronic Acid; Severity of Illness Index; Tablets, Enteric-Coated; Technetium Tc 99m Pentetate; Water | 2006 |